U.S. FDA Announces Draft E6 (R3) Guideline for Good Clinical Practice (GCP)

On June 6, 2023, the U.S. Food and Drug Administration released the draft E6 (R3) Guideline for Good Clinical Practice for public comments. The draft is open to public comments until June 9, 2023.